New Potomac Partners’s Colgate-Palmolive CL Stock Holding History

New Potomac Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200	Closed	-$15K	–	149
2017 Q4	$15K	Buy	+200	New	+$14.6K	0.01%	124

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

New Potomac Partners's CL Position: Q1 2018 in Review

New Potomac Partners sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 200 shares — an estimated $15K sold.

New Potomac Partners first reported a position in CL in Q4 2017 and held it in 1 quarter. The position peaked at $15K in Q4 2017. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

New Potomac Partners reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
New Potomac Partners sold 200 Colgate-Palmolive shares in Q1 2018, an estimated $15K.
New Potomac Partners first reported a position in Colgate-Palmolive in Q4 2017 and held it in 1 quarter.
New Potomac Partners's Colgate-Palmolive position peaked at $15K in Q4 2017.
1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on New Potomac Partners's 13F filing for Q1 2018, filed 18 Apr 2018.